Table 4.
Sociodemographic, clinical, and psychological characteristics and QoL issues of subjects with FD and OD
| Characteristics | FD (total = 232), n (%) | OD (total = 114), n (%) | P value |
| Age | 0.104 | ||
| Less than 50 yr | 174 (75) | 76 (66.7) | |
| Age 50 yr or above | 58 (25) | 38 (33.3) | |
| Sex | <0.001 | ||
| Male | 76 (32.8) | 62 (54.4) | |
| Female | 156 (67.2) | 52 (45.6) | |
| Marital status | 0.752 | ||
| Married | 196 (84.5) | 98 (86) | |
| Single | 36 (15.5) | 16 (14) | |
| Education, n (%) | 0.133 | ||
| Illiterate and up to class V | 126 (54.3) | 72 (63.2) | |
| Class VI and above | 106 (45.7) | 42 (36.8) | |
| Family incomea | 0.732 | ||
| Lower income | 178 (76.7) | 87 (78.4) | |
| Higher income | 54 (23.3) | 24 (21.6) | |
| Occupation | 0.002 | ||
| Homemaking | 152 (65.5) | 49 (43.0) | |
| Cultivation | 28 (12.1) | 29 (24.3) | |
| Business and others | 52 (22.4) | 36 (31.6) | |
| Religion | 0.386 | ||
| Muslim | 157 (68) | 83 (72.8) | |
| Hindu | 74 (32) | 31 (27.2) | |
| History of smoking (current or past) | 38 (16.5) | 30 (26.5) | 0.031 |
| History of acute gastroenteritis | 54 (23.3) | 20 (17.5) | 0.222 |
| Use of NSAIDs and aspirin | 3 (1.3) | 8 (7) | 0.004 |
| Dyspepsia subtype | 0.538 | ||
| EPS alone | 35 (15.1) | 18 (15.8) | |
| PDS alone | 73 (31.5) | 42 (36.8) | |
| EPS-PDS overlap | 124 (53.4) | 54 (47.4) | |
| H. pylori positivity | 174 (75) | 92 (80.7) | 0.174 |
| IBS | 66 (28.4) | 26 (22.8) | 0.264 |
| Heartburn | 88 (37.9) | 44 (38.6) | 0.905 |
| Presence of psychological distress | 22 (9.5) | 7 (6.1) | 0.292 |
| Impaired QoL | 0.906 | ||
| Abdominal pain | 87 (57.5) | 44 (38.6) | 0.480 |
| Meal-related symptoms | 55 (23.7) | 28 (24.6) |
EPS, epigastric pain syndrome; FD, functional dyspepsia; IBS, irritable bowel syndrome; QoL, quality of life; NSAIDs, nonsteroidal anti-inflammatory drugs; OD, organic dyspepsia; PDS, postprandial distress syndrome.
a
Lower family income, 10,000 taka/mo and higher family income. 10,000 taka/mo.1 US$ = 84.84 taka (dated August 30, 2020).